Sign Up to like & get
recommendations!
1
Published in 2023 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001475
Abstract: Background. Here we test the hypothesis that, like CD81-associated “latent” IL35, the transforming growth factor (TGF)β:latency-associated peptide (LAP)/glycoprotein A repetitions predominant (GARP) complex was also tethered to small extracellular vesicles (sEVs), aka exosomes, produced by…
read more here.
Keywords:
garp tgf;
tgf;
tgf lap;
tolerance ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood"
DOI: 10.1182/blood.2022017097
Abstract: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by clonal expansion of myeloid cells, notably megakaryocytes (MKs), and aberrant cytokine production leading to bone marrow (BM) fibrosis and insufficiency. Current treatment options are limited. TGF-b1,…
read more here.
Keywords:
cell;
tgf blockade;
garp;
garp tgf ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.704050
Abstract: When combined with anti-PD-1, monoclonal antibodies (mAbs) against GARP:TGF-β1 complexes induced more frequent immune-mediated rejections of CT26 and MC38 murine tumors than anti-PD-1 alone. In both types of tumors, the activity of anti-GARP:TGF-β1 mAbs resulted…
read more here.
Keywords:
infiltration;
garp tgf;
blockade;
tgf ... See more keywords